409 related articles for article (PubMed ID: 25892506)
1. Neuroprotection in Parkinsonian-treated mice via estrogen receptor α activation requires G protein-coupled estrogen receptor 1.
Bourque M; Morissette M; Di Paolo T
Neuropharmacology; 2015 Aug; 95():343-52. PubMed ID: 25892506
[TBL] [Abstract][Full Text] [Related]
2. Implication of GPER1 in neuroprotection in a mouse model of Parkinson's disease.
Bourque M; Morissette M; Côté M; Soulet D; Di Paolo T
Neurobiol Aging; 2013 Mar; 34(3):887-901. PubMed ID: 22749492
[TBL] [Abstract][Full Text] [Related]
3. Raloxifene activates G protein-coupled estrogen receptor 1/Akt signaling to protect dopamine neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice.
Bourque M; Morissette M; Di Paolo T
Neurobiol Aging; 2014 Oct; 35(10):2347-56. PubMed ID: 24726471
[TBL] [Abstract][Full Text] [Related]
4. Contribution of estrogen receptor subtypes, ERα, ERβ, and GPER1 in rapid estradiol-mediated enhancement of hippocampal synaptic transmission in mice.
Kumar A; Bean LA; Rani A; Jackson T; Foster TC
Hippocampus; 2015 Dec; 25(12):1556-66. PubMed ID: 25980457
[TBL] [Abstract][Full Text] [Related]
5. Implication of the phosphatidylinositol-3 kinase/protein kinase B signaling pathway in the neuroprotective effect of estradiol in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice.
D'Astous M; Mendez P; Morissette M; Garcia-Segura LM; Di Paolo T
Mol Pharmacol; 2006 Apr; 69(4):1492-8. PubMed ID: 16434614
[TBL] [Abstract][Full Text] [Related]
6. Differential contribution of estrogen receptors to the intestinal therapeutic effects of 17β-estradiol in a murine model of Parkinson's disease.
Poirier AA; Côté M; Bourque M; Jarras H; Lamontagne-Proulx J; Morissette M; Paolo TD; Soulet D
Brain Res Bull; 2022 Sep; 187():85-97. PubMed ID: 35781029
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptors and gonadal steroids in vulnerability and protection of dopamine neurons in a mouse model of Parkinson's disease.
Al-Sweidi S; Morissette M; Bourque M; Di Paolo T
Neuropharmacology; 2011 Sep; 61(4):583-91. PubMed ID: 21586296
[TBL] [Abstract][Full Text] [Related]
8. GPER1-mediated immunomodulation and neuroprotection in the myenteric plexus of a mouse model of Parkinson's disease.
Côté M; Bourque M; Poirier AA; Aubé B; Morissette M; Di Paolo T; Soulet D
Neurobiol Dis; 2015 Oct; 82():99-113. PubMed ID: 26051538
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptors modulate striatal metabotropic receptor type 5 in intact and MPTP male mice model of Parkinson's disease.
Al-Sweidi S; Morissette M; Di Paolo T
J Steroid Biochem Mol Biol; 2016 Jul; 161():84-91. PubMed ID: 26873133
[TBL] [Abstract][Full Text] [Related]
10. Estrogen reduces BDNF level, but maintains dopaminergic cell density in the striatum of MPTP mouse model.
Tripanichkul W; Gerdprasert O; Jaroensuppaperch EO
Int J Neurosci; 2010 Jul; 120(7):489-95. PubMed ID: 20583901
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor alpha and beta differentially regulate intracellular Ca(2+) dynamics leading to ERK phosphorylation and estrogen neuroprotection in hippocampal neurons.
Zhao L; Brinton RD
Brain Res; 2007 Oct; 1172():48-59. PubMed ID: 17803971
[TBL] [Abstract][Full Text] [Related]
12. Oestrogen receptors and signalling pathways: implications for neuroprotective effects of sex steroids in Parkinson's disease.
Al Sweidi S; Sánchez MG; Bourque M; Morissette M; Dluzen D; Di Paolo T
J Neuroendocrinol; 2012 Jan; 24(1):48-61. PubMed ID: 21790809
[TBL] [Abstract][Full Text] [Related]
13. Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice.
Sathiya S; Ranju V; Kalaivani P; Priya RJ; Sumathy H; Sunil AG; Babu CS
Neuropharmacology; 2013 Oct; 73():98-110. PubMed ID: 23747572
[TBL] [Abstract][Full Text] [Related]
14. The key involvement of estrogen receptor β and G-protein-coupled receptor 30 in the neuroprotective action of daidzein.
Kajta M; Rzemieniec J; Litwa E; Lason W; Lenartowicz M; Krzeptowski W; Wojtowicz AK
Neuroscience; 2013 May; 238():345-60. PubMed ID: 23419549
[TBL] [Abstract][Full Text] [Related]
15. Isoflavones Mediate Dendritogenesis Mainly through Estrogen Receptor α.
Ariyani W; Amano I; Koibuchi N
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240356
[TBL] [Abstract][Full Text] [Related]
16. Effect of estrogen receptor agonists treatment in MPTP mice: evidence of neuroprotection by an ER alpha agonist.
D'Astous M; Morissette M; Di Paolo T
Neuropharmacology; 2004 Dec; 47(8):1180-8. PubMed ID: 15567427
[TBL] [Abstract][Full Text] [Related]
17. G Protein-Coupled Estrogen Receptor 1 Mediates Acute Estrogen-Induced Cardioprotection via MEK/ERK/GSK-3β Pathway after Ischemia/Reperfusion.
Kabir ME; Singh H; Lu R; Olde B; Leeb-Lundberg LM; Bopassa JC
PLoS One; 2015; 10(9):e0135988. PubMed ID: 26356837
[TBL] [Abstract][Full Text] [Related]
18. Estrogen modulates in vitro T cell responses in a concentration- and receptor-dependent manner: effects on intracellular molecular targets and antioxidant enzymes.
Priyanka HP; Krishnan HC; Singh RV; Hima L; Thyagarajan S
Mol Immunol; 2013 Dec; 56(4):328-39. PubMed ID: 23911387
[TBL] [Abstract][Full Text] [Related]
19. Activation of the G protein-coupled estrogen receptor, but not estrogen receptor α or β, rapidly enhances social learning.
Ervin KS; Mulvale E; Gallagher N; Roussel V; Choleris E
Psychoneuroendocrinology; 2015 Aug; 58():51-66. PubMed ID: 25957002
[TBL] [Abstract][Full Text] [Related]
20. G protein-coupled estrogen receptor1 (GPER1) may mediate Rho-kinase (ROCK-2) up-regulation in coronary endothelial cells.
Kurt AH; Tiftik RN; Un I; Ulker S; Buyukafsar K
Endocr Regul; 2013 Apr; 47(2):75-84. PubMed ID: 23641788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
